10.46EUR-2.24%Mkt Cap: 131.85M EURP/E: —Last update: 2026-06-01
Guerbet SA provides a range of contrast media, medical devices, and digital and AI solutions for diagnostic and interventional imaging worldwide. It offers DOTAREM, a macrocyclic gadolinium-based contrast agent for use i…
Industry Peers
Medical DevicesIndicators:|
Key Statistics
Company
Market Cap131.85M EUR
Enterprise Value453.76M EUR
Revenue (TTM)798.67M EUR
Gross Profit566.19M EUR
Net Income (TTM)-108.33M EUR
Revenue/Share63.31 EUR
Last Price10.46 EUR
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees2.7K
CountryFR
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)4.38
PEG0.07
EV/EBITDA9.87
EV/Revenue0.57
P/S0.17
P/B0.51
EPS (TTM)-8.91
EPS (Forward)2.44
52W Range
8.01016% of range23.70
52W High23.70 EUR
52W Low8.010 EUR
Profitability
Gross Margin70.89%
Oper. Margin-1.70%
EBITDA Margin5.76%
Profit Margin-13.56%
ROE-40.57%
ROA-11.65%
Growth
Revenue Growth-5.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF81.09M EUR
CapEx (TTM)36.61M EUR
FCF Margin9.29%
FCF Yield56.29%
Net Debt325.70M EUR
Net Debt/EBITDA7.08
Balance Sheet
Debt/Equity1.65
Current Ratio2.49
Quick Ratio1.08
Book Value/Sh21.16 EUR
Cash/Share9.158 EUR
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 EUR
Div. Yield—
5Y Avg Yield2.65%
Payout Ratio0.00%
Ex-Div DateJul 1, 2024
Pay Date—
Splits
Last Split4:1
Split DateJan 23, 2014
Analyst Consensus
Rating3.7 (Underperform)
Target (Mean)11.60 EUR
Target Range9.000 EUR – 13.80 EUR
# Analysts3
Ownership
Shares Out.12.61M
Float5.26M
Insiders63.21%
Institutions7.89%
Technical
SMA 509.989 (+4.7%)
SMA 20013.73 (-23.8%)
Beta0.99
S&P 52W Chg27.94%
Avg Vol (30d)14.86K
Avg Vol (10d)16.65K
Technical Indicators
RSI (14)57.1
MACD-0.0025
MACD Signal-0.0698
MACD Hist.+0.0673
BB Upper11.28 EUR
BB Middle10.29 EUR
BB Lower9.300 EUR
BB Width19.28%
ATR (14)0.4076 EUR
Vol Ratio (20d)0.95x